News|Articles|December 8, 2025
Dos and Don’ts of oligonucleotide analysis
Author(s)SCIEX
Explore best practices for LC-MS analysis of oligonucleotides to get the best results possible, quickly and easily.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
2
Novartis Calls for Global Governments to Address Global Trade Policy
3
Generative AI and Adaptive Trials Shape Future Biotech Development
4
Executive Summary: From Molecule to Formulation: A Systematic Approach to Assess Biologics Developability
5